ClinConnect ClinConnect Logo
Search / Trial NCT03010150

Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer

Launched by M.D. ANDERSON CANCER CENTER · Jan 3, 2017

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how well people with metastatic head and neck cancer stick to their swallowing exercises after receiving radiation treatment. The study uses blood tests to check for certain proteins in the immune system, called cytokines, and questionnaires to understand why some people might not follow their exercise routines. By learning about these factors, doctors hope to find out how they can help patients better manage side effects and possibly reduce the risk of future health issues.

To be eligible for this trial, participants should be planning to receive radiation treatment for specific types of head and neck cancers, such as oropharyngeal or laryngeal cancers, and they should be at certain stages of their disease. Participants can expect to provide blood samples and answer questions about their exercise habits. It’s important to note that individuals with other types of cancer or previous treatments for head and neck cancer are not eligible for this study. This research aims to improve support for patients undergoing treatment and enhance their overall recovery experience.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Are dispositioned to receive radiation with curative intent for nasopharyngeal, oropharyngeal, hypopharyngeal, laryngeal, or an unknown primary cancer with cervical metastases
  • Are stage II-IVb for non- human papillomavirus (HPV)- related oropharyngeal cancer
  • Have HPV- related oropharynx cancer that is T1, have nodal involvement with no distant metastasis or have HPV- related oropharynx cancer that is at least T2 with no distant metastasis
  • Are stage II-IVb for laryngeal cancer
  • Are stage I-IVb for hypopharyngeal
  • Are stage I-IVb for nasopharyngeal cancer
  • Have stage I-III unknown primary cancer with cervical
  • Exclusion Criteria:
  • Have other cancer diagnoses, except non-melanoma skin cancer
  • Had treatment for previous head and neck cancer or radiation to the head and neck
  • Have a history of previous head and neck surgery (excluding biopsy and/or tonsillectomy and/or tracheotomy)
  • Have a current oropharyngeal dysphagia unrelated to cancer diagnosis (e.g., dysphagia due to underlying neurogenic disorder)

About M.D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.

Locations

Houston, Texas, United States

Patients applied

0 patients applied

Trial Officials

Eileen H Shinn

Principal Investigator

M.D. Anderson Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials